531126 Sigma-AldrichMPNST Inhibitor, Cpd21 - CAS 62289-81-0 - Calbiochem
A cell-permeable. Reversible, selective inhibitor of the growth of malignant peripheral nerve sheath tumors (EC₅₀ = 439 nM, 754 nM, and 1.0 µM in S462, SNF96.2, and sMPNST cells).
More>> A cell-permeable. Reversible, selective inhibitor of the growth of malignant peripheral nerve sheath tumors (EC₅₀ = 439 nM, 754 nM, and 1.0 µM in S462, SNF96.2, and sMPNST cells). Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Synonyms: N-(Pyridin-3-yl)thiophene-2-carboxamide, Malignant Peripheral Nerve Sheath Tumors Inhibitor, Cpd 21
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 62289-81-0 | C₁₀H₈N₂OS |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 5.31126.0001 |
|
Glass bottle | 25 mg |
|
— |
| Description | |
|---|---|
| Overview | A cell-permeable, bioavailable, non-toxic pyridinylthiophene-carboxamide compound that preferentially and reversibly inhibits the growth of malignant peripheral nerve sheath tumors (MPNSTs) in both human and murine models in a dose-dependent manner (EC50 = 439 nM, 754 nM, and 1.0 µM in S462, SNF96.2, and sMPNST cells). Exhibits toxicity towards neurofibromatosis type 1 (Nf1) and p53 deficient MPNST cells, but does not affect normally dividing Schwann cells and mouse embryonic fibroblasts. Shown to reduce ATP consumption by all MPNST cells studied (EC50 = 1.0 µM). Synergizes with PI-3 Kinase inhibitor, LY-294002 (Cat. Nos. 440202 & 440204) to block the growth of MPNST cells. Reduces the expression of cyclin A2, B1, D1, E, cdk4, and cdk6 and increases the expression of cdkn1a and cdkn2a in a dose dependent manner. Blocks cell cycle at G1/S phase leading to apoptosis in cancer cells. Displays favorable pharmacokinetic profile and is rapidly distributed from the plasma into sMPNST tissues and has a half-life of 6-8 hours in sMPNST tissue following its complete distribution. Reduces MPNST burden in a mouse allograft model and enhances survival (~40 mg/kg, i.p. in mice for 4 weeks). Please note that the molecular weight for this compound is batch-specific due to variable water content. |
| Catalogue Number | 531126 |
| Brand Family | Calbiochem® |
| Synonyms | N-(Pyridin-3-yl)thiophene-2-carboxamide, Malignant Peripheral Nerve Sheath Tumors Inhibitor, Cpd 21 |
| References | |
|---|---|
| References | Chau, V., et al. 2013. Cancer Res. 74, 586. |
| Product Information | |
|---|---|
| CAS number | 62289-81-0 |
| Form | Light beige solid |
| Hill Formula | C₁₀H₈N₂OS |
| Chemical formula | C₁₀H₈N₂OS |
| Reversible | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 5.31126.0001 | 04055977242621 |
Documentation
MPNST Inhibitor, Cpd21 - CAS 62289-81-0 - Calbiochem SDS
| Title |
|---|
References
| Reference overview |
|---|
| Chau, V., et al. 2013. Cancer Res. 74, 586. |
| Data Sheet | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
|